SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Spironolactone And Hydrochlorothiazide, and when can generic versions of Spironolactone And Hydrochlorothiazide launch?
Spironolactone And Hydrochlorothiazide is a drug marketed by Ascot, Chartwell Rx, Mutual Pharm, Mylan, Purepac Pharm, Sun Pharm Industries, Superpharm, and Watson Labs. and is included in eight NDAs.
The generic ingredient in SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; spironolactone. There are thirty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; spironolactone profile page.
Summary for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 9 |
Patent Applications: | 31 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE? | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE excipients list |
DailyMed Link: | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Chiang Mai University | Phase 3 |
Medical University of Bialystok | N/A |
Shanghai Jiao Tong University School of Medicine | Phase 4 |
See all SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Drug Class | Aldosterone Antagonist Thiazide Diuretic |
Mechanism of Action | Aldosterone Antagonists |
Physiological Effect | Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
US Patents and Regulatory Information for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ascot | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 088025-001 | Nov 23, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Superpharm | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 089137-001 | Aug 26, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 086513-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087398-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |